Metraipolis › archive › dc_2cb7dbcda9f4

Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges — Europe PMC PMID:37103352

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37103352
DOI
10.3390/md21040211
License (as archived)
solo-consultazione
Archived
2026-10-08T07:48:20.351Z
SHA-256 of the archived text
591c29801684cea5085aad1d310c7eaf891dfba9ca63e8e2adf3de78aab5f595
Stable URL of this page
https://metraipolis.com/documento/dc_2cb7dbcda9f4

How to cite

Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges — Europe PMC PMID:37103352 — Europe PMC (en), https://europepmc.org/article/MED/37103352 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2cb7dbcda9f4 (Metraipolis archive dc_2cb7dbcda9f4, sha256 591c29801684cea5085aad1d310c7eaf891dfba9ca63e8e2adf3de78aab5f595)
BibTeX
@misc{dc2cb7dbcda9f4,
  title = {Chitosan Nanoparticles-Based Cancer Drug Delivery: Application and Challenges — Europe PMC PMID:37103352},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37103352},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2cb7dbcda9f4; sha256 591c29801684cea5085aad1d310c7eaf891dfba9ca63e8e2adf3de78aab5f595},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37103352. Agents can read the archived copy with the MCP tool read_document.